F. Qian

发表

Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma

B. Han, Bo Jin, F. Qian, 2017, The Journal of thoracic and cardiovascular surgery.

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC

B. Han, F. Qian, Yanwei Zhang, 2021, Frontiers in Oncology.

Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy

B. Han, Xueyan Zhang, H. Zhong, 2019, Annals of Surgical Oncology.

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study

B. Han, F. Qian, Yanwei Zhang, 2021, Frontiers in Oncology.

Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma

Wei Zhang, Jun Lu, F. Qian, 2022, Annals of Surgical Oncology.

Pembrolizumab Plus Chemotherapy Versus Chemotherapy Monotherapy as a First-Line Treatment in Elderly Patients (≥75 Years Old) With Non-Small-Cell Lung Cancer

F. Qian, Yanwei Zhang, Bo-wen Zhang, 2022, Frontiers in Immunology.

Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study

Jun Lu, F. Qian, Shu-yuan Wang, 2022, Thoracic cancer.

Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer

Jun Lu, Y. Lou, F. Qian, 2022, Thoracic cancer.

Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma

Wei Zhang, Jun Lu, F. Qian, 2022, Annals of Surgical Oncology.

PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway

B. Han, Jun Lu, Y. Lou, 2020, Cancer Cell International.

Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer

B. Han, F. Qian, 2020, Chinese medical journal.

Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung

Jun Lu, F. Qian, Yanwei Zhang, 2021, Frontiers in Oncology.

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

B. Han, Ping Yang, K. Gu, 2021, Oncoimmunology.

Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening.

B. Han, Huimin Wang, L. Pilz, 2018, Lung cancer.

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma

Huimin Wang, Jun Lu, Y. Lou, 2022, Cancer medicine.

Adjuvant Chemotherapy Improves Survival in Surgically Resected Stage IB Squamous Lung Cancer.

B. Han, Xueyan Zhang, H. Zhong, 2019, The Annals of thoracic surgery.

Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion

B. Han, R. Qiao, F. Qian, 2018, The Journal of thoracic and cardiovascular surgery.

Screening for early stage lung cancer and its correlation with lung nodule detection.

B. Han, Xueyan Zhang, Baohui Han, 2018, Journal of thoracic disease.

The centromere-associated protein CENPU promotes cell proliferation, migration, and invasiveness in lung adenocarcinoma.

Huimin Wang, H. Zhong, Jun Lu, 2022, Cancer letters.

Prognostic and Predictive Value of Blood Tumor Mutational Burden in Patients With Lung Cancer Treated With Docetaxel.

B. Han, K. Gu, Midie Xu, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab

B. Han, K. Gu, Midie Xu, 2020, Oncoimmunology.

Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas

B. Han, Jun Lu, R. Qiao, 2018, Cancer.

Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?

B. Han, Xueyan Zhang, Huimin Wang, 2018, Lung cancer.

Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2).

Wei Zhang, Yu Dong, F. Qian, 2022, Lung cancer.

DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation

B. Han, Midie Xu, Jun Lu, 2021, Acta pharmacologica Sinica.

DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation

B. Han, Midie Xu, Jun Lu, 2021, Acta Pharmacologica Sinica.

China lung cancer screening (CLUS) version 2.0 with new techniques implemented: Artificial intelligence, circulating molecular biomarkers and autofluorescence bronchoscopy.

Hong Yu, Jiancheng Yang, Huimin Wang, 2023, Lung cancer.

EP01.03-010 China Lung Cancer Screening Study (CLUS) Version 2.0: Study Design and Baseline Screening Results

F. Qian, B. Han, Y. Zhang, 2022, Journal of Thoracic Oncology.

High‐resolution Computed Tomography Features Distinguishing Benign and Malignant Lesions Manifesting as Persistent Solitary Subsolid Nodules

B. Han, W. Fang, F. Qian, 2018, Clinical lung cancer.

P1.03-062 Lung Cancer Screening with Low-Dose CT in China: Study Design and Baseline Results from the First Round Screening Arm

B. Han, Bo Jin, Xueyan Zhang, 2017 .

Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer.

B. Han, F. Qian, Ya Chen, 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Efficacy of ICI-based treatment in advanced NSCLC patients with PD-L1≥50% who developed EGFR-TKI resistance

Jun Lu, Y. Lou, F. Qian, 2023, Frontiers in Immunology.

A randomized double-blind trial of TQB2450 with or without anlotinib in pretreated driver-negative non-small cell lung cancer.

Jing Zhu, Yu Dong, H. Zhong, 2023, Lung cancer.

Predicting malignancy of pulmonary ground-glass nodules and their invasiveness by random forest.

Xiaodan Ye, Timothy Deyer, Jingyi Zeng, 2018, Journal of thoracic disease.

PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs.

H. Zhong, Jun Lu, Y. Lou, 2023, Journal of controlled release : official journal of the Controlled Release Society.